Mirati Therapeutics To Present At Upcoming Healthcare Conferences
(WorldNews Canada)

SAN DIEGO, Sept. 19, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York on Tuesday, September 26 at 1:40 p.m. ET/ 10:40 a.m. PT. Mirati will also participate in the Leerink Partners Roundtable Series - Rare Disease & Immuno-Oncology Conference in New York...